Drug Type AAV based gene therapy |
Synonyms |
Target |
Mechanism GLA stimulants(α-Galactosidase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization M6P TherapeuticsStartup |
Active Organization M6P TherapeuticsStartup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fabry Disease | Preclinical | US | M6P TherapeuticsStartup | 22 Aug 2024 |